首页> 美国卫生研究院文献>American Journal of Cancer Research >Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells
【2h】

Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells

机译:雄激素受体扩大了上尿路尿路上皮细胞癌细胞中的癌症干细胞种群

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Androgen receptor (AR) affects the development and progression of upper urinary tract urothelial cell carcinoma (UUTUC). However, the regulatory mechanism exerted by AR to affect UUTUC cells remains unclear. Here we investigated whether AR promotes UUTUC development and progression, possibly by expanding the population of cancer stem cells (CSCs), which are a particular population of cells within cancer cells responsible for tumor initiation, drug resistance and metastasis. We compared UUTUC cells with or without the addition of AR on their CSC population with flow cytometry, colony formation and sphere formation assay to determine the effect of AR on CSC activity, and real-time PCR was used to detect the expression stemness genes and miRNAs. In vivo tumor formation was evaluated with the implantation of cancer cells in nude mice. We found that the addition of AR in UUTUC cells, significantly increased the population of CSC, clonogenicity, sphere formation and the expression of stemness genes (Oct4, Bmi1 and Nanog), altered CSC-related miRNA profile, as well as promoted epithelial mesenchymal transition (EMT). And AR inhibitor, enzalutamide was shown to suppress AR’s effect on tumorsphere formation. Furthermore, in an immune-deficient mouse model, the addition of AR in UUTUC cells also increased the tumor formation capacity. This study will help us better understand the extent to which AR contributes to UUTUC progression by expanding their CSC population and capacity. Our findings could explain high incidence of UUTUC observed in males. And targeting AR may lead to novel therapeutic approaches for genetically diversified urothelial carcinomas in precision medicine era.
机译:雄激素受体(AR)影响上尿路尿路上皮细胞癌(UUTUC)的发展和进程。但是,AR影响UUTUC细胞的调控机制仍不清楚。在这里,我们研究了AR是否促进UUTUC的发展和进程,可能是通过扩大癌干细胞(CSCs)的数量来实现的,CSC是癌细胞中负责肿瘤起始,耐药性和转移的特定细胞群体。我们通过流式细胞术,集落形成和球形成试验比较了在CSC群体上添加或不添加AR的UUTUC细胞,以确定AR对CSC活性的影响,并使用实时PCR检测表达干基因和miRNA 。通过在裸鼠中植入癌细胞来评估体内肿瘤的形成。我们发现,在UUTUC细胞中添加AR,显着增加了CSC的种群,克隆形成,球形成和干基因(Oct4,Bmi1和Nanog)的表达,改变了CSC相关的miRNA谱以及促进了上皮间充质转化(EMT)。 AR抑制剂enzalutamide被证明可以抑制AR对肿瘤球形成的影响。此外,在免疫缺陷的小鼠模型中,在UUTUC细胞中添加AR也增加了肿瘤形成能力。这项研究将帮助我们更好地了解AR通过扩大其CSC人口和能力在多大程度上促进UUTUC的进展。我们的发现可以解释男性中UUTUC的高发病率。在精准医学时代,靶向AR可能会为遗传上多样化的尿路上皮癌带来新的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号